Invivyd, Inc. (IVVD) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 206.45M USD. 52-week range 0.5280 to 3.07 USD. Data as of 2026-10-09.
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase ...